Literature DB >> 17119185

Clinical features of bacterial conjunctivitis in children.

Parul B Patel1, Maria Carmen G Diaz, Jonathan E Bennett, Magdy W Attia.   

Abstract

OBJECTIVES: Conjunctivitis is a common cause of primary care and emergency department (ED) visits. There is a paucity of data in recent literature on the prevalence of pediatric bacterial conjunctivitis, and there are no evidence-based clinical guidelines for empirical treatment. The study objective was to describe clinical features most predictive of bacterial conjunctivitis.
METHODS: This was a prospective study in a children's hospital ED. Conjunctival swabs for bacterial culture were obtained from patients aged 1 month to 18 years presenting with red or pink eye and/or the diagnosis of conjunctivitis.
RESULTS: A total of 111 patients were enrolled over one year. Patients had a mean (+/-SD) age of 33.2 (+/-37.5) months, and 55% were male. Eighty-seven patients (78%) had positive bacterial cultures. Nontypeable Haemophilus influenzae accounted for 82% (71/87), Streptococcus pneumoniae for 16% (14/87), and Staphylococcus aureus for 2.2% (2/87). Five clinical variables were significantly associated with a positive bacterial culture. Regression analysis revealed that the combination of a history of gluey or sticky eyelids and the physical finding of mucoid or purulent discharge had a posttest probability of 96% (95% confidence interval = 90% to 99%). Subjective scoring by physicians for a positive culture was 50.6%.
CONCLUSIONS: Conjunctivitis in children is predominantly bacterial, with nontypeable H. influenzae being the most common organism. A history of gluey or sticky eyelids and physical findings of mucoid or purulent discharge are highly predictive of bacterial infection. Based on the above data, empirical ophthalmic antibiotic therapy may be appropriate in children presenting with conjunctivitis.

Entities:  

Mesh:

Year:  2006        PMID: 17119185     DOI: 10.1197/j.aem.2006.08.006

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  15 in total

1.  Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.

Authors:  Timothy L Comstock; Michael R Paterno; Dale W Usner; Michael E Pichichero
Journal:  Paediatr Drugs       Date:  2010-04-01       Impact factor: 3.022

2.  The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

Authors:  Jose Benitez-Del-Castillo; Yves Verboven; David Stroman; Laurent Kodjikian
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

3.  Assessment of Streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection.

Authors:  Erin W Norcross; Nathan A Tullos; Sidney D Taylor; Melissa E Sanders; Mary E Marquart
Journal:  Curr Eye Res       Date:  2010-09       Impact factor: 2.424

4.  Ophthalmic antibiotic use for acute infectious conjunctivitis in children.

Authors:  Holly M Frost; Thresia Sebastian; Josh Durfee; Timothy C Jenkins
Journal:  J AAPOS       Date:  2021-11-02       Impact factor: 1.325

5.  An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite.

Authors:  David Granet; Steven J Lichtenstein; Bruce Onofrey; James A Katz
Journal:  Clin Ophthalmol       Date:  2007-12

Review 6.  Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

7.  Antibacterial activity of betle leaf (Piper betle l.) extract on inhibiting Staphylococcus aureus in conjunctivitis patient.

Authors:  Rodiah Rahmawaty Lubis; Dian Dwi Wahyuni
Journal:  Am J Clin Exp Immunol       Date:  2020-02-25

8.  Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis.

Authors:  Lorenzo J Cervantes; Francis S Mah
Journal:  Clin Ophthalmol       Date:  2011-04-18

9.  Sap transporter mediated import and subsequent degradation of antimicrobial peptides in Haemophilus.

Authors:  Catherine L Shelton; Forrest K Raffel; Wandy L Beatty; Sara M Johnson; Kevin M Mason
Journal:  PLoS Pathog       Date:  2011-11-03       Impact factor: 6.823

10.  Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis.

Authors:  Dominique Bremond-Gignac; Hachemi Nezzar; Paolo Emilio Bianchi; Riadh Messaoud; Sihem Lazreg; Liliana Voinea; Claude Speeg-Schatz; Dahbia Hartani; Thomas Kaercher; Beata Kocyla-Karczmarewicz; Joaquim Murta; Laurent Delval; Didier Renault; Frédéric Chiambaretta
Journal:  Br J Ophthalmol       Date:  2014-02-13       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.